Enrolls First Subject in Phase 2 RECLAIM Trial of Pemvidutide in Alcohol Use Disorder [Internet]
180 In a prospective cross-sectional study conducted by Sen et al 181 involving 124 patients scheduled for elective surgery under general anesthesia, gastric ultrasound revealed retained gastric contents in 35 of 62 patients receiving GLP-1RAs therapy versus 12 of 62 controls, despite adherence to the current fasting guidelines in both cohorts
Sporadic reports of skeletal muscle decline highlight the need for careful monitoring, as sarcopenia, characterized by reduced muscle mass and impaired physical function, may worsen metabolic outcomes and increase morbidity [19, 20]
Despite the intricate interplay of pathological mechanisms in AD, therapeutic efforts have long prioritized A targeting as a singular strategy
Help your brain work better Be more aware of your daily tasks and feel more often in the zone thanks to NADs impact on a cellular level across your body
The FDA approved these peptides in July 2026. It did not